Schedule 13G ownership disclosure

Eton Pharmaceuticals Inc

Security class unavailable · CUSIP: 29772L108

Event date: 2021-02-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,084,329
Percent of class
4.4800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-024351
Form type
SC 13G/A
Filer
APPEL PETER A
CIK
CIK 1227104
Filed
Feb 16, 2021
Reporting period
Feb 04, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub